Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
Total Valuation
Idexx Laboratories has a market cap or net worth of $32.95B. The enterprise value is $34.82B.
Market Cap$32.95B
Enterprise Value$34.82B
Share Statistics
Idexx Laboratories has 81,039,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding81,039,040
Owned by Insiders0.98%
Owned by Institutions1.03%
Financial Efficiency
Idexx Laboratories’s return on equity (ROE) is 0.56 and return on invested capital (ROIC) is 33.87%.
Return on Equity (ROE)0.56
Return on Assets (ROA)0.27
Return on Invested Capital (ROIC)33.87%
Return on Capital Employed (ROCE)0.51
Revenue Per Employee354.32K
Profits Per Employee80.72K
Employee Count11,000
Asset Turnover1.18
Inventory Turnover3.98
Valuation Ratios
The current PE Ratio of Idexx Laboratories is 38.33. Idexx Laboratories’s PEG ratio is 6.29.
PE Ratio38.33
PS Ratio8.78
PB Ratio21.33
Price to Fair Value21.33
Price to FCF42.64
Price to Operating Cash Flow36.63
PEG Ratio6.29
Income Statement
In the last 12 months, Idexx Laboratories had revenue of 3.90B and earned 887.87M in profits. Earnings per share was 10.79.
Revenue3.90B
Gross Profit2.38B
Operating Income1.13B
Pretax Income1.11B
Net Income887.87M
EBITDA1.27B
Earnings Per Share (EPS)10.79
Cash Flow
In the last 12 months, operating cash flow was 929.00M and capital expenditures -130.92M, giving a free cash flow of 798.08M billion.
Operating Cash Flow929.00M
Free Cash Flow798.08M
Free Cash Flow per Share9.85
Dividends & Yields
Idexx Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change-14.62%
50-Day Moving Average425.98
200-Day Moving Average449.26
Relative Strength Index (RSI)48.94
Average Volume (3m)920.35K
Important Dates
Idexx Laboratories upcoming earnings date is May 1, 2025, TBA Not Confirmed.
Last Earnings DateFeb 3, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend Date―
Financial Position
Idexx Laboratories as a current ratio of 1.31, with Debt / Equity ratio of 61.87%
Current Ratio1.31
Quick Ratio0.95
Debt to Market Cap0.03
Net Debt to EBITDA0.55
Interest Coverage Ratio36.16
Taxes
In the past 12 months, Idexx Laboratories has paid 221.96M in taxes.
Income Tax221.96M
Effective Tax Rate0.20
Enterprise Valuation
Idexx Laboratories EV to EBITDA ratio is 27.32, with an EV/FCF ratio of 43.51.
EV to Sales8.91
EV to EBITDA27.32
EV to Free Cash Flow43.51
EV to Operating Cash Flow37.38
Balance Sheet
Idexx Laboratories has $288.27M in cash and marketable securities with $162.28M in debt, giving a net cash position of $698.68M billion.
Cash & Marketable Securities$288.27M
Total Debt$162.28M
Net Cash$698.68M
Net Cash Per Share$8.62
Tangible Book Value Per Share$13.10
Margins
Gross margin is 61.08%, with operating margin of 28.95%, and net profit margin of 22.78%.
Gross Margin61.08%
Operating Margin28.95%
Pretax Margin28.48%
Net Profit Margin22.78%
EBITDA Margin32.61%
EBIT Margin29.28%
Analyst Forecast
The average price target for Idexx Laboratories is $504.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$504.00
Price Target Upside19.55% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast6.46%
EPS Growth Forecast5.82%